| Case Name | Date Filed | Judge | Drug | Patent No(s). |
|---|---|---|---|---|
| Gilead Sciences, Inc. v. Watson Labs., Inc., 15-0289 (D. Del.) | Apr. 1, 2015 | Hon. Sue L. Robinson | Letairis® (ambrisentan tablets) | RE42,462 |
| Coalition for Affordable Drugs II LLC v. Shire Inc., IPR2015-00988 (PTAB) | Apr. 1, 2015 | N/A | Lialda® (mesalamine delayed-release tablets) | 6,773,720 |
| Elan Pharma International Ltd. v. Actavis Labs. UT, Inc., 15-0291 (D. Del.) | Apr. 2, 2015 | Hon. Leonard P. Stark | Clindesse® (clindamycin phosphate vaginal cream) | 6,899,890 |
| Merck Sharp & Dohme Corp. v. Apotex Inc., 15-2384 (D.N.J.) | Apr. 2, 2015 | Hon. Peter G. Sheridan | Nasonex® (mometasone furoate nasal spray) | 6,127,353 |
| Gilead Sciences, Inc. v. Watson Labs., Inc., 15-2350 (D. Del.) | Apr. 3, 2015 | Hon. Kevin McNulty | Letairis® (ambrisentan tablets) | RE42,462 |
| Sanofi-Aventis U.S. LLC v. Accord Healthcare, Inc., 15-2520 (D.N.J.) | Apr. 6, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel Injection) | 8,927,592 |
| Sanofi-Aventis U.S. LLC v. BPI Labs, LLC, 15-2521 (D.N.J.) | Apr. 6, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel Injection) | 8,927,592 |
| Sanofi-Aventis U.S. LLC v. Dr. Reddy’s Labs., Inc., 15-2522 (D.N.J.) | Apr. 6, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel Injection) | 8,927,592 |
| Sanofi-Aventis U.S. LLC v. Glenmark Generics Inc., 15-2523 (D.N.J.) | Apr. 6, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel Injection) | 8,927,592 |
| Coalition for Affordable Drugs III LLC v. Jazz Pharms., Inc., IPR2015-01018 (PTAB) | Apr. 6, 2015 | N/A | Xyrem® (sodium oxybate oral solution) | 7,895,059 |
| Supernus Pharms., Inc. v. Actavis Inc., 15-2499 (D.N.J.) | Apr. 7, 2015 | Hon. Renee Marie Bumb | Oxtellar XR® (oxcarbazepine extended-release tablets) | 8,821,930 |
| Elan Pharma International Ltd. v. Actavis Labs. UT, Inc., 15-2528 (D.N.J.) | Apr. 8, 2015 | Hon. Jose L. Linares | Clindesse® (clindamycin phosphate vaginal cream) | 6,899,890 |
| Janssen Products, L.P. v. Cipla Ltd., 15-2549 (D.N.J.) | Apr. 9, 2015 | Hon. William H. Walls | Prezista® (darunavir tablets) |
7,700,645
8,518,987
7,126,015
7,595,408
|
| Lupin Ltd. v. Janssen Sciences Ireland UC, IPR2015-01030 (PTAB) | Apr. 9, 2015 | N/A | Prezista® (darunavir tablets) | 8,518,987 |
| Teva Pharms. USA, Inc. v. Dr. Reddy’s Labs., Ltd., 15-0306 (D. Del.) | Apr. 10, 2015 | Hon. Gregory M. Sleet | Copaxone® (glatiramer acetate for injection) | 8,969,302 |
| Janssen Products, L.P. v. Cipla Ltd., 15-0307 (D. Del.) | Apr. 10, 2015 | Hon. Sue L. Robinson | Prezista® (darunavir tablets) |
7,700,645
8,518,987
7,126,015
7,595,408
|
| U.S. Dept. of Health and Human Services v. Cipla Ltd., 15-2571 (D.N.J.) | Apr. 10, 2015 | Hon. William H. Walls | Prezista® (darunavir tablets) |
7,470,506
8,597,876
|
| Sanofi-Aventis U.S. LLC v. Fresenius Kabi USA, LLC., 15-2631 (D.N.J.) | Apr. 13, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel Injection) | 8,927,592 |
| Mylan Pharms. Inc. v. Nissan Chemical Industries Ltd., IPR2015-01069 (PTAB) | Apr. 18, 2015 | N/A | Livalo® (pitavastatin calcium tablets) | 5,856,336 |
| Shire Development LLC v. Amneal Pharms. LLC, 15-2865 (D.N.J.) | Apr. 22, 2015 | Hon. Joseph E. Irenas | Lialda® (mesalamine delayed-release tablets) | 6,773,720 |
| Medicis Pharm. Corp. v. Taro Pharms. U.S.A., Inc., 15-2841 (D.N.J.) | Apr. 22, 2015 | Hon. Renee Marie Bumb | Zyclara® (imiquimod 3.75% cream) |
8,236,816
8,598,196
8,598,196
|
| Coalition For Affordable Drugs V LLC v. Biogen IDEC International GmbH, IPR2015-01086 (PTAB) | Apr. 22, 2015 | N/A | Tecfidera® (dimethyl fumarate delayed-release capsules) | 8,759,393 |
| Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01092 (PTAB) | Apr. 22, 2015 | N/A |
Revlimid® (lenalidomide capsules)
Pomalyst® (pomalidomide capsules)
Thalomid® (thalidomide capsules)
|
6,045,501 |
| Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0328 (D. Del.) | Apr. 23, 2015 | Hon. Leonard P. Stark | Minivelle® (estradiol transdermal system) |
6,841,716
8,231,906
|
| Coalition For Affordable Drugs II LLC v. NPS Pharms., Inc., IPR2015-01093 (PTAB) | Apr. 23, 2015 | N/A | Gattex Kit® (recombinant teduglutide subcutaneous powder) | 7,056,886 |
| Coalition For Affordable Drugs VI LLC v. Celgene, IPR2015-01096 (PTAB) | Apr. 23, 2015 | N/A | Revlimid® (lenalidomide capsules) | 6,315,720 |
| Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01097 (PTAB) | Apr. 23, 2015 | N/A | Prolensa® (bromfenac ophthalmic solution) | 8,754,131 |
| Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01099 (PTAB) | Apr. 23, 2015 | N/A | Prolensa® (bromfenac ophthalmic solution) | 8,669,290 |
| Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01100 (PTAB) | Apr. 23, 2015 | N/A | Prolensa® (bromfenac ophthalmic solution) | 8,927,606 |
| Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01102 (PTAB) | Apr. 23, 2015 | N/A | Pomalyst® (pomalidomide capsules) | 6,315,720 |
| Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01103 (PTAB) | Apr. 23, 2015 | N/A | Thalomid® (thalidomide capsules) | 6,315,720 |
| Lupin Ltd. v. Senju Pharm. Co., Ltd., IPR2015-01105 (PTAB) | Apr. 23, 2015 | N/A | Prolensa® (bromfenac ophthalmic solution) | 8,871,813 |
| Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0069 (N.D.W.V.) | Apr. 24, 2015 | Hon. Irene M. Keeley | Minivelle® (estradiol transdermal system) |
6,841,716
8,231,906
|
| Apotex, Inc. v. Daiichi Sankyo, Inc., 15-3695 (N.D. Ill.) | Apr. 27, 2015 | Hon. Rebecca R. Pallmeyer | Benicar® HCT (olmesartan medoxomil / hydrochlorothiazide tablets) | 6,878,703 |
| Eli Lilly and Co. v. Lupin Ltd., 15-0673 (S.D. Ind.) | Apr. 27, 2015 | Hon. Sarah Evans Barker | Effient® (prasugrel hydrochloride tablets) |
8,404,703
8,569,325
|
| Par Pharm., Inc. v. Hyperion Therapeutics, Inc., IPR2015-01117 (PTAB) | Apr. 29, 2015 | N/A | Ravicti® (glycerol phenylbutyrate oral liquid) | 8,642,012 |
| Par Pharm., Inc. v. Hyperion Therapeutics, Inc., IPR2015-01127 (PTAB) | Apr. 29, 2015 | N/A | Ravicti® (glycerol phenylbutyrate oral liquid) | 8,404,215 |
| Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-3051 (D.N.J.) | Apr. 30, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) |
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
|
| Sanofi-Aventis U.S. LLC v. Actavis LLC, 15-3107 (D.N.J.) | May 1, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel injection) | 8,927,592 |
| Bausch & Lomb Inc. v. Micro Labs USA, Inc., 15-3113 (D.N.J.) | May 1, 2015 | Hon. Noel L. Hillman | Bepreve® (bepotastine besilate ophthalmic solution) | 8,877,168 |
| Apotex Inc. v. Lupin Ltd., 15-0599 (E.D. Tex.) | May 1, 2015 | Hon. Robert W. Schroeder, III | Paxil CR® (paroxetine hydrochloride controlled-release tablets) | 7,229,640 |
| Coalition For Affordable Drugs V LLC v. Biogen MA Inc., IPR2015-01136 (PTAB) | May 1, 2015 | N/A | Tecfidera® (dimethyl fumarate delayed-release capsules) | 8,399,514 |
| Apotex Inc. v. Lupin Ltd., 15-0357 (D. Del.) | May 4, 2015 | Hon. Leonard P. Stark | Paxil CR® (paroxetine hydrochloride controlled-release tablets) | 7,229,640 |
| Vanda Pharms. Inc. v. Inventia Healthcare Pvt. Ltd., 15-0362 (D. Del.) | May 5, 2015 | Hon. Gregory M. Sleet | Fanapt® (iloperidone tablets) | 8,586,610 |
| Galderma Labs., L.P. v. Glenmark Generics Inc., USA, 15-1416 (N.D. Tex.) | May 6, 2015 | Hon. Barbara M. G. Lynn | Epiduo® (adapalene /benzoyl peroxide gel) |
8,071,644
8,080,537
8,129,362
8,445,543
8,809,305
|
| Jazz Pharms., Inc. v. Amneal Pharms., LLC, 15-3217 (D.N.J.) | May 7, 2015 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) | 8,952,062 |
| Coalition For Affordable Drugs VI LLC v. Celgene Corp., IPR2015-01169 (PTAB) | May 7, 2015 | N/A | Revlimid® (lenalidomide capsules) Pomalyst® (pomalidomide capsules) | 5,635,517 |
| Senju Pharm. Co., Ltd. v. Innopharma Licensing, Inc., 15-3240 (D.N.J.) | May 8, 2015 | Hon. Jerome B. Simandle | Prolensa® (bromfenac ophthalmic solution) |
8,129,431
8,669,290
8,754,131
8,871,813
8,927,606
|
| Altaire Pharms., Inc. v. Paragon Biotek, Inc., PGR2015-00011 (PTAB) | May 11, 2015 | N/A | Phenylephrine Hydrochloride (phenylephrine hydrochloride ophthalmic solution) | 8,859,623 |
| Duchesnay Inc. v. Mylan Pharms. Inc., 15-0385 (D. Del.) | May 13, 2015 | Hon. Sue L. Robinson | Diclegis® (doxylamine succinate / pyridoxine hydrochloride delayed-release tablets) | 6,340,695 |
| Horizon Pharma, Inc. v. Actavis Labs. FL., Inc., 15-3322 (D.N.J.) | May 13, 2015 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,852,636
8,858,996
|
| Horizon Pharma, Inc. v. Dr. Reddy’s Labs. Inc., 15-3324 (D.N.J.) | May 13, 2015 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,852,636
8,858,996
|
| Horizon Pharma, Inc. v. Lupin Ltd., 15-3326 (D.N.J.) | May 13, 2015 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,852,636
8,858,996
|
| Horizon Pharma, Inc. v. Mylan Pharms. Inc., 15-3327 (D.N.J.) | May 13, 2015 | Hon. Mary L. Cooper | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) |
8,852,636
8,858,996
|
| Merz Pharms., LLC v. Taro Pharms. U.S.A., Inc., 15-3720 (S.D.N.Y.) | May 14, 2015 | Hon. William H. Pauley, III | Naftin® (naftifine hydrochloride gel) | 8,778,365 |
| Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-3367 (D.N.J.) | May 15, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) |
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
|
| Takeda GmbH v. Torrent Pharma Inc., 15-3375 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Micro Labs USA, Inc., 15-3376 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Zydus Pharms. (USA) Inc., 15-3377 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Strides Pharma, Inc., 15-3378 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Apotex Corp., 15-3379 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Prinston Pharm. Inc., 15-3380 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
5,712,298
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Breckenridge Pharm. Inc., 15-3382 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
5,712,298
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Citron Pharma LLC, 15-3383 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Mylan Pharms. Inc., 15-3384 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
5,712,298
8,536,206
8,604,064
8,618,142
|
| Takeda GmbH v. Hetero USA Inc., 15-3385 (D.N.J.) | May 15, 2015 | Hon. Freda L. Wolfson | Daliresp® (roflumilast tablets) |
8,536,206
8,618,142
8,618,142
|
| Acorda Therapeutics, Inc. v. Sun Pharm. Indus. Ltd., 15-0391 (D. Del.) | May 15, 2015 | Hon. Leonard P. Stark | Ampyra® (dalfampridine extended-release tablets) |
8,007,826
8,354,437
8,440,703
8,663,685
|
| Sanofi-Aventis U.S. LLC v. Onco Therapies Ltd., 15-3392 (D.N.J.) | May 15, 2015 | Hon. Michael A. Shipp | Jevtana® Kit (cabazitaxel injection) | 8,927,592 |
| Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-0393 (D. Del.) | May 15, 2015 | Hon. Gregory M. Sleet | Quillivant® (methylphenidate hydrochloride extended-release oral suspension) | 8,956,649 |
| Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-3399 (D.N.J.) | May 15, 2015 | Hon. Madeline C. Arleo | Quillivant® (methylphenidate hydrochloride extended-release oral suspension) | 8,956,649 |
| Vanda Pharms. Inc. v. Inventia Healthcare Pvt. Ltd., 15-0059 (N.D.W.V.) | May 15, 2015 | Hon. Gina M. Groh | Fanapt® (iloperidone tablets) | 8,586,610 |
| Akorn, Inc. v. Senju Pharm. Co., Ltd., IPR2015-01205 (PTAB) | May 15, 2015 | N/A | Durezol® (difluprednate ophthalmic emulsion) | 6,114,319 |
| Cephalon, Inc. v. Apotex Inc., 15-0404 (D. Del.) | May 19, 2015 | Hon. Gregory M. Sleet | Treanda® (bendamustine hydrochloride for infusion) |
8,445,524
8,436,190
8,609,863
8,791,270
8,669,279
8,883,836
8,895,756
|
| Merck & CIE v. Lupin Ltd., 15-0407 (D. Del.) | May 20, 2015 | Hon. Richard G. Andrews | Safyral® (drospirenone / 17α-ethinylestradiol / levomefolate calcium tablets) | 6,441,168 |
| Eli Lilly and Co. v. HEC Pharm USA, Inc., 15-0792 (S.D. Ind.) | May 20, 2015 | Hon. Jane Magnus-Stinson | Effient® (prasugrel hydrochloride tablets) |
8,404,703
8,569,325
|
| Recro Technology LLC v. Actavis Labs. FL., Inc., 15-0413 (D. Del.) | May 21, 2015 | Hon. Gregory M. Sleet | Zohydro® (hydrocodone bitartrate extended-release capsules) |
6,228,398
6,902,742
|
| Sanofi v. Lupin Atlantis Holdings S.A., 15-0415 (D. Del.) | May 21, 2015 | Hon. Richard G. Andrews | Multaq® (dronedarone tablets) |
8,318,800
8,410,167
|
| Merck & CIE v. Lupin Ltd., 15-1472 (D. Md.) | May 21, 2015 | Hon. J. Frederick Motz | Safyral® (drospirenone / 17α-ethinylestradiol / levomefolate calcium tablets) | 6,441,168 |
| Horizon Pharma Ireland Ltd. v. IGI Labs., Inc., 15-3508 (D.N.J.) | May 21, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) |
8,217,078
8,252,838
8,546,450
8,563,613
8,618,164
8,871,809
|
| Coalition for Affordable Drugs VII LLC v. Pozen Inc., IPR2015-01241 (PTAB) | May 21, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 6,926,907 |
| Kowa Co., Ltd. v. Lupin Ltd, 15-3935 (S.D.N.Y.) | May 21, 2015 | Hon. Paul A. Crotty | Livalo® (pitavastatin calcium tablets) | 8,557,993 |
| Kowa Co., Ltd. v. Lupin Ltd, 15-1495 (D. Md.) | May 22, 2015 | Hon. George Jarrod Hazel | Livalo® (pitavastatin calcium tablets) | 8,557,993 |
| Cipla Ltd. v. Sunovion Pharms. Inc., 15-0424 (D. Del.) | May 26, 2015 | Hon. Leonard P. Stark | Xopenex HFA® (levalbuterol tartrate) | RE43,984 |
| Janssen Pharms., Inc. v. Vintage Pharms. LLC, 15-3542 (D.N.J.) | May 26, 2015 | Hon. Stanley R. Chesler | Ortho Tri-cyclen® Lo (norgestimate / ethinyl estradiol tablets) | 6,214,815 |
| Duchesnay Inc. v. Mylan Pharms. Inc., 15-0092 (N.D.W.V.) | May 27, 2015 | Hon. Irene M. Keeley | Diclegis® (doxylamine succinate / pyridoxine hydrochloride delayed-release tablets) | 6,340,695 |
| Takeda GmbH v. Mylan Pharms. Inc., 15-0093 (N.D.W.V.) | May 27, 2015 | Hon. Irene M. Keeley | Daliresp® (roflumilast tablets) |
5,712,298
8,536,206
8,604,064
8,618,142
|
| Janssen Pharms., Inc. v. Vintage Pharms. LLC, 15-0429 (D. Del.) | May 28, 2015 | Hon. Richard G. Andrews | Ortho Tri-cyclen® Lo (norgestimate / ethinyl estradiol tablets) | 6,214,815 |
| Forest Labs., LLC v. Amneal Pharms., LLC, 15-0430 (D. Del.) | May 28, 2015 | Hon. Sue L. Robinson | Saphris® (asenapine maleate tablets) | 5,763,476 |
| Warner Chilcott Co., LLC v. Amneal Pharms. LLC, 15-3590 (D.N.J.) | May 28, 2015 | Hon. Mary L. Cooper | Minastrin® 24 Fe (ethinyl estradiol / norethindrone acetate / ferrous fumarate tablets) | 6,667,050 |
| Novartis Pharms. Corp. v. Apotex, Inc., 15-3634 (D.N.J.) | May 29, 2015 | Hon. Susan D. Wigenton | Zometa® (zoledronic acid concentrate for intravenous infusion) | 8,324,189 |
| Fresenius Kabi USA, LLC v. Fera Pharms., LLC, 15-3654 (D.N.J.) | May 29, 2015 | Hon. Claire C. Cecchi | Levothyroxine Sodium (levothyroxine sodium powder for injection) | 9,006,289 |
| Fresenius Kabi USA, LLC v. Innopharma Licensing, LLC, 15-3655 (D.N.J.) | May 29, 2015 | Hon. Claire C. Cecchi | Levothyroxine Sodium (levothyroxine sodium powder for injection) | 9,006,289 |
| Mylan Pharms., Inc. v. Janssen Pharms., Inc., 15-2990 (E.D. Pa.) | May 29, 2015 | Hon. Mark A. Kearney | Concerta® (methylphenidate hydrochloride extended-release tablets) | 8,629,179 |
| Jazz Pharms., Inc. v. Roxane Labs., Inc., 15-3684 (D.N.J.) | June 1, 2015 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) | 8,952,062 |
| Takeda Pharm. Co. Ltd. v. Actavis Labs. FL, Inc., 15-0451 (D. Del.) | June 3, 2015 | Hon. Richard G. Andrews | Contrave® (naltrexone hydrochloride / bupropion hydrochloride extended-release tablets) |
7,375,111
7,462,626
8,088,786
8,318,788
8,722,085
8,815,889
8,916,195
|
| Teijin Ltd. v. Macleods Pharms. Ltd., 15-0454 (D. Del.) | June 4, 2015 | Hon. Sue L. Robinson | Uloric® (febuxostat tablets) | 7,361,676 |
| Apotex Corp. v. Allergan, Inc., IPR2015-01278 (PTAB) | June 4, 2015 | N/A | Restasis® (cyclosporine ophthalmic emulsion) | 8,633,162 |
| Apotex Corp. v. Allergan, Inc., IPR2015-01282 (PTAB) | June 4, 2015 | N/A | Restasis® (cyclosporine ophthalmic emulsion) | 8,629,111 |
| Apotex Corp. v. Allergan, Inc., IPR2015-01283 (PTAB) | June 4, 2015 | N/A | Restasis® (cyclosporine ophthalmic emulsion) | 8,685,930 |
| Apotex Corp. v. Allergan, Inc., IPR2015-01284 (PTAB) | June 4, 2015 | N/A | Restasis® (cyclosporine ophthalmic emulsion) | 8,648,048 |
| Apotex Corp. v. Allergan, Inc., IPR2015-01286 (PTAB) | June 4, 2015 | N/A | Restasis® (cyclosporine ophthalmic emulsion) | 8,642,556 |
| Mylan Pharms., Inc. v. AstraZeneca AB, IPR2015-01340 (PTAB) | June 4, 2015 | N/A |
Onglyza® (saxagliptin hydrochloride tablets) Kombiglyze® XR (metformin hydrochloride /
saxagliptin hydrochloride extended-release tablets)
|
RE44,186 |
| Bayer Pharma AG v. Macleods Pharms. Ltd., 15-0464 (D. Del.) | June 5, 2015 | Hon. Gregory M. Sleet | Staxyn® (vardenafil hydrochloride tablets) | 8,613,950 |
| Mallinckrodt LLC v. Watson Labs., Inc.-Florida, 15-3800 (D.N.J.) | June 5, 2015 | Hon. Katharine S. Hayden | Xartemis® XR (acetaminophen / oxycodone hydrochloride extended-release tablets) |
8,597,681
8,658,631
8,741,885
8,980,319
8,992,975
7,976,870
8,668,929
|
| Bausch & Lomb Inc. v. Apotex Inc., 15-3879 (D.N.J.) | June 5, 2015 | Hon. Noel L. Hillman | Bepreve® (bepotastine besilate ophthalmic solution) |
8,784,789
8,877,168
|
| Coalition for Affordable Drugs VII LLC v. Pozen Inc., IPR2015-01344 (PTAB) | June 5, 2015 | N/A | Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets) | 8,858,996 |
| Actavis Labs. UT, Inc. v. UCB, Inc., 15-1001 (E.D. Tex.) | June 8, 2015 | Hon. Rodney Gilstrap | Neupro® (rotigotine transdermal system) | 7,921,999 |
| Fresenius Kabi USA, LLC v. Par Sterile Products, LLC, 15-3852 (D.N.J.) | June 9, 2015 | Hon. Claire C. Cecchi | Levothyroxine Sodium (levothyroxine sodium powder for injection) | 9,006,289 |
| Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-0474 (D. Del.) | June 10, 2015 | Hon. Richard G. Andrews | Afinitor® (everolimus tablets) |
9,006,224
8,410,131
|
| Novartis Pharms. Corp. v. Par Pharm., Inc., 15-0475 (D. Del.) | June 10, 2015 | Hon. Richard G. Andrews | Afinitor® (everolimus tablets) | 9,006,224 |
| Reckitt Benckiser Pharms. Inc. v. Alvogen Pine Brook, Inc., 15-0477 (D. Del.) | June 10, 2015 | Hon. Richard G. Andrews | Suboxone (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) |
8,475,832
8,017,150
8,603,514
8,900,497
8,906,277
|
| Alcon Research, Ltd. v. Akorn Inc., 15-0479 (D. Del.) | June 11, 2015 | Hon. Sue L. Robinson | Travatan Z® (travoprost ophthalmic solution) |
8,268,299
8,323,630
8,388,941
|
| Par Pharm., Inc. v. Breckenridge Pharm., Inc., 15-0486 (D. Del.) | June 12, 2015 | Hon. Sue L. Robinson | Megace® ES (megestrol acetate oral suspension) | 9,040,088 |
| Meda Pharms. Inc. v. Roxane Labs., Inc., 15-0510 (D. Del.) | June 17, 2015 | Hon. Gregory M. Sleet | Astepro® (azelastine hydrochloride nasal spray) |
8,071,073
8,518,919
|
| Hetero Labs Ltd. Unit V v. Pharmacia & Upjohn Co. LLC, 15-5396 (N.D. Ill.) | June 18, 2015 | Hon. Matthew F. Kennelly | Zyvox® (linezolid tablets) |
6,514,529
6,559,305
|
| Ferring B.V. v. Actavis, Inc., 15-4222 (D.N.J.) | June 23, 2015 | Hon. Katharine S. Hayden | Lysteda® (tranexamic acid tablets) | 9,060,939 |
| Cephalon, Inc. v. Fresenius Kabi USA, LLC, 15-0536 (D. Del.) | June 24, 2015 | Hon. Leonard P. Stark | Treanda® (bendamustine hydrochloride for infusion) | 8,344,006 |
| Pharmacosmos A/S v. Luitpold Pharms., Inc., IPR2015-01490 (PTAB) | June 24, 2015 | N/A | Injectafer® (ferric carboxymaltose for injection) | 7,754,702 |
| Pharmacosmos A/S v. Luitpold Pharms., Inc., IPR2015-01495 (PTAB) | June 24, 2015 | N/A | Injectafer® (ferric carboxymaltose for injection) | 8,895,612 |
| Millennium Pharms., Inc. v. Dr. Reddy’s Labs., Ltd., 15-0539 (D. Del.) | June 25, 2015 | Hon. Gregory M. Sleet | Velcade® (bortezomib for injection) |
6,713,446
6,958,319
|
| Novartis Pharms. Corp. v. Aurobindo Pharma Ltd., 15-4427 (D.N.J.) | June 25, 2015 | Hon. Susan D. Wigenton | Zometa® (zoledronic acid concentrate for intravenous infusion) | 8,324,189 |
| Reckitt Benckiser LLC v. Dr. Reddy’s Labs., Inc., 15-4524 (D.N.J.) | June 26, 2015 | Hon. Renee Marie Bumb | Mucinex® D (guaifenesin / pseudoephedrine hydrochloride extended-release tablets) |
6,372,252
6,955,821
7,838,032
|
| Jazz Pharms., Inc. v. Watson Labs., Inc., 15-4532 (D.N.J.) | June 26, 2015 | Hon. Esther Salas | Xyrem® (sodium oxybate oral solution) |
8,859,619
8,952,062
|
| Salix Pharms., Inc. v. Mylan Pharms., Inc., 15-0109 (N.D.W.V.) | June 26, 2015 | Hon. Irene M. Keeley | Apriso® (mesalamine extended-release capsules) |
6,551,620
8,337,886
8,496,965
8,865,688
|
| Panacea Biotec Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01492 (PTAB) | June 26, 2015 | N/A | Effient® (prasugrel hydrochloride tablets) | 8,569,325 |
| Panacea Biotec Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01496 (PTAB) | June 26, 2015 | N/A | Effient® (prasugrel hydrochloride tablets) | 8,404,703 |
| Gilead Sciences, Inc. v. Sigmapharm Labs., LLC, 15-4898 (D.N.J.) | June 30, 2015 | Hon. Renee Marie Bumb | Letairis® (ambrisentan tablets) | RE42,462 |
| Horizon Pharma Ireland Ltd. v. Taro Pharms. USA, Inc., 15-5021 (D.N.J.) | June 30, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,066,913 |
| Horizon Pharma Ireland Ltd. v. IGI Pharms., Inc., 15-5022 (D.N.J.) | June 30, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,066,913 |
| Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-5024 (D.N.J.) | June 30, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,066,913 |
| Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 15-5025 (D.N.J.) | June 30, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,066,913 |
| Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-5027 (D.N.J.) | June 30, 2015 | Hon. Noel L. Hillman | Pennsaid® (diclofenac sodium topical solution) | 9,066,913 |
